BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24397032)

  • 1. [Synthesis and properties of 5-fluorouracil derivatives].
    Semakov AV; Blinkov AA; Gaenko GP; Vostrova AG; Molotkovskiĭ IuG
    Bioorg Khim; 2013; 39(3):338-45. PubMed ID: 24397032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis of 5-fluorouracil derivatives containing alkanoic acid].
    Xu LH; Weng LL; Zheng H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):644-6. PubMed ID: 16909623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil-lipid conjugate: potential candidate for drug delivery through encapsulation in hydrophobic polyester-based nanoparticles.
    Ashwanikumar N; Kumar NA; Asha Nair S; Vinod Kumar GS
    Acta Biomater; 2014 Nov; 10(11):4685-4694. PubMed ID: 25110286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and properties of N-nicotinoyl-2-(5-fluorouracil-1-yl)-D,L-glycine ester as a prodrug of 5-fluorouracil for rectal administration.
    Yang YW; Lee JS; Kim I; Jung YJ; Kim YM
    Eur J Pharm Biopharm; 2007 May; 66(2):260-7. PubMed ID: 17182232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumor activity of 1- or 3-(alpha-hetero substituted)alkyl-5-fluorouracil derivatives.
    Ozaki S; Nagase T; Ahmad S; Tamai H; Hoshi A; Iigo M
    Nucleic Acids Symp Ser; 1987; (18):1-4. PubMed ID: 3697106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of 3-acetyl-5-fluorouracil (5-FU): implication for its rearrangements during hydrolysis and upon heating.
    Beall HD; Prankerd RJ; Todaro LJ; Sloan KB
    Pharm Res; 1993 Jun; 10(6):905-12. PubMed ID: 8321861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of N(3)-O-toluyl-fluorouracil-loaded liposomes.
    Sun W; Zhang N; Li A; Zou W; Xu W
    Int J Pharm; 2008 Apr; 353(1-2):243-50. PubMed ID: 18155370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical studies of N₃-O-toluyl-fluorouracil-loaded lipid-based nanosuspensions in H₂₂-bearing mice.
    Zhang J; Li M; Liu Z; Wang L; Liu Y; Zhang N
    Int J Nanomedicine; 2014; 9():2741-51. PubMed ID: 24920908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the synthesis of chemotherapeutics. 10. Synthesis and antitumor activity of N-acyl- and N-(alkoxycarbonyl)-5-fluorouracil derivatives.
    Kametani T; Kigasawa K; Hiiragi M; Wakisaka K; Haga S; Nagamatsu Y; Sugi H; Fukawa K; Irino O; Yamamoto T; Nishimura N; Taguchi A; Okada T; Nakayama M
    J Med Chem; 1980 Dec; 23(12):1324-9. PubMed ID: 7452684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value?. An animal study in VX-2 liver tumor-bearing rabbits.
    Pohlen U; Binnenhei M; Reszka R; Buhr HJ; Berger G
    Chemotherapy; 2004 Jun; 50(2):67-75. PubMed ID: 15211080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor activity of conjugates of 5-Fluorouracil and emodin.
    Zhao LM; Zhang LM; Liu JJ; Wan LJ; Chen YQ; Zhang SQ; Yan ZW; Jiang JH
    Eur J Med Chem; 2012 Jan; 47(1):255-60. PubMed ID: 22093761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthesis and antitumor activity of new heterocyclic 5-fluorouracil derivatives].
    Mao M; Chen Y; Tian X
    Yao Xue Xue Bao; 1998 May; 33(5):389-91. PubMed ID: 12017008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies on 5-florouracil-loaded DTPA-PE containing nanosized pegylated liposomes for diagnosis and treatment of tumor.
    Liko F; Erdoğan S; Özer YA; Vural I
    J Liposome Res; 2013 Mar; 23(1):61-9. PubMed ID: 23363305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and bioevaluation of 5-fluorouracil derivatives.
    Tian ZY; Du GJ; Xie SQ; Zhao J; Gao WY; Wang CJ
    Molecules; 2007 Nov; 12(11):2450-7. PubMed ID: 18065949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of N-acyl-2-(5-fluorouracil-1-yl)-D,L-glycine as a colon-specific prodrug of 5-fluorouracil.
    Lee JS; Jung YJ; Kim YM
    J Pharm Sci; 2001 Nov; 90(11):1787-94. PubMed ID: 11745736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrugs of 5-fluorouracil. VII. Hydrolysis kinetics and physicochemical properties of N-ethoxy- and N-phenoxycarbonyloxymethyl derivatives of 5-fluorouracil.
    Buur A; Bundgaard H; Falch E
    Acta Pharm Suec; 1986; 23(4):205-16. PubMed ID: 3799213
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synthesis of N1-(aryl)alkyloxyacyl-5-fluorouracil derivatives].
    Hai L; Wu LY; Huang J; Cheng L; Wu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 35(4):552-4. PubMed ID: 15291126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumoural properties of benzannelated seven-membered 5-fluorouracil derivatives and related open analogues. Molecular markers for apoptosis and cell cycle dysregulation.
    Espinosa A; Marchal JA; Aránega A; Gallo MA; Aiello S; Campos J
    Farmaco; 2005 Feb; 60(2):91-7. PubMed ID: 15752467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved chemical syntheses of 5,6-dihydro-5-fluorouracil.
    LaFrate AL; Katzenellenbogen JA
    J Org Chem; 2007 Oct; 72(22):8573-6. PubMed ID: 17900141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-erythrocyte membrane-chaperoned 5-fluorouracil liposomes as biomimetic delivery platforms to target hepatocellular carcinoma cell lines.
    AlQahtani SA; Harisa GI; Badran MM; AlGhamdi KM; Kumar A; Salem-Bekhit MM; Ahmad SF; Alanazi FK
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):989-996. PubMed ID: 30873877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.